nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.127	0.282	CbGbCtD
Tadalafil—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.086	0.19	CbGbCtD
Tadalafil—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0821	0.182	CbGbCtD
Tadalafil—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0732	0.162	CbGbCtD
Tadalafil—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0429	0.0949	CbGbCtD
Tadalafil—PDE5A—pulmonary artery—chronic obstructive pulmonary disease	0.0427	0.649	CbGeAlD
Tadalafil—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0405	0.0897	CbGbCtD
Tadalafil—PDE5A—respiratory system—chronic obstructive pulmonary disease	0.00719	0.109	CbGeAlD
Tadalafil—PDE5A—connective tissue—chronic obstructive pulmonary disease	0.00633	0.0961	CbGeAlD
Tadalafil—PDE5A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00579	0.0879	CbGeAlD
Tadalafil—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00463	0.0583	CbGpPWpGaD
Tadalafil—PDE11A—Nitric oxide stimulates guanylate cyclase—NOS2—chronic obstructive pulmonary disease	0.00445	0.0561	CbGpPWpGaD
Tadalafil—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00409	0.0515	CbGpPWpGaD
Tadalafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS2—chronic obstructive pulmonary disease	0.00397	0.05	CbGpPWpGaD
Tadalafil—PDE5A—lung—chronic obstructive pulmonary disease	0.00382	0.058	CbGeAlD
Tadalafil—PDE11A—Nitric oxide stimulates guanylate cyclase—NOS3—chronic obstructive pulmonary disease	0.00358	0.0451	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.0035	0.044	CbGpPWpGaD
Tadalafil—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00335	0.0421	CbGpPWpGaD
Tadalafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS3—chronic obstructive pulmonary disease	0.00319	0.0402	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.00177	0.0223	CbGpPWpGaD
Tadalafil—PDE11A—Platelet homeostasis—NOS2—chronic obstructive pulmonary disease	0.00173	0.0218	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.00171	0.0216	CbGpPWpGaD
Tadalafil—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0017	0.0214	CbGpPWpGaD
Tadalafil—PDE5A—Platelet homeostasis—NOS2—chronic obstructive pulmonary disease	0.00155	0.0195	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.00153	0.0192	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.0015	0.0189	CbGpPWpGaD
Tadalafil—PDE11A—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	0.00139	0.0176	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.00133	0.0168	CbGpPWpGaD
Tadalafil—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.0013	0.0164	CbGpPWpGaD
Tadalafil—PDE5A—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	0.00124	0.0156	CbGpPWpGaD
Tadalafil—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00101	0.0127	CbGpPWpGaD
Tadalafil—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000877	0.011	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.00086	0.0108	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000838	0.0105	CbGpPWpGaD
Tadalafil—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000798	0.01	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000767	0.00965	CbGpPWpGaD
Tadalafil—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000764	0.00962	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000746	0.00939	CbGpPWpGaD
Tadalafil—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000733	0.00923	CbGpPWpGaD
Tadalafil—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000732	0.00182	CcSEcCtD
Tadalafil—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000732	0.00182	CcSEcCtD
Tadalafil—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000726	0.0018	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000723	0.0018	CcSEcCtD
Tadalafil—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000722	0.00179	CcSEcCtD
Tadalafil—Cough—Formoterol—chronic obstructive pulmonary disease	0.000722	0.00179	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000717	0.00903	CbGpPWpGaD
Tadalafil—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000717	0.00178	CcSEcCtD
Tadalafil—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000716	0.00178	CcSEcCtD
Tadalafil—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000715	0.00178	CcSEcCtD
Tadalafil—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000715	0.00178	CcSEcCtD
Tadalafil—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000714	0.00177	CcSEcCtD
Tadalafil—Cough—Montelukast—chronic obstructive pulmonary disease	0.000708	0.00176	CcSEcCtD
Tadalafil—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000705	0.00888	CbGpPWpGaD
Tadalafil—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000705	0.00175	CcSEcCtD
Tadalafil—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000705	0.00175	CcSEcCtD
Tadalafil—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000705	0.00175	CcSEcCtD
Tadalafil—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000705	0.00175	CcSEcCtD
Tadalafil—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000705	0.00175	CcSEcCtD
Tadalafil—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000705	0.00175	CcSEcCtD
Tadalafil—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000705	0.00175	CcSEcCtD
Tadalafil—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000703	0.00174	CcSEcCtD
Tadalafil—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000702	0.00174	CcSEcCtD
Tadalafil—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000702	0.00174	CcSEcCtD
Tadalafil—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000701	0.00174	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.0007	0.00174	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.0007	0.00174	CcSEcCtD
Tadalafil—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000696	0.00173	CcSEcCtD
Tadalafil—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000696	0.00173	CcSEcCtD
Tadalafil—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000691	0.00172	CcSEcCtD
Tadalafil—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00069	0.00171	CcSEcCtD
Tadalafil—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00069	0.00171	CcSEcCtD
Tadalafil—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000689	0.00171	CcSEcCtD
Tadalafil—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000689	0.00171	CcSEcCtD
Tadalafil—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000687	0.00171	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000686	0.0017	CcSEcCtD
Tadalafil—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000685	0.0017	CcSEcCtD
Tadalafil—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000682	0.00169	CcSEcCtD
Tadalafil—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000681	0.00169	CcSEcCtD
Tadalafil—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000676	0.00168	CcSEcCtD
Tadalafil—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000676	0.00168	CcSEcCtD
Tadalafil—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000675	0.00168	CcSEcCtD
Tadalafil—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000671	0.00167	CcSEcCtD
Tadalafil—Infection—Formoterol—chronic obstructive pulmonary disease	0.000671	0.00167	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000669	0.00842	CbGpPWpGaD
Tadalafil—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000665	0.00165	CcSEcCtD
Tadalafil—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000665	0.00165	CcSEcCtD
Tadalafil—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000665	0.00165	CcSEcCtD
Tadalafil—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000665	0.00165	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000665	0.00837	CbGpPWpGaD
Tadalafil—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000663	0.00165	CcSEcCtD
Tadalafil—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000663	0.00165	CcSEcCtD
Tadalafil—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000662	0.00164	CcSEcCtD
Tadalafil—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000662	0.00164	CcSEcCtD
Tadalafil—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000659	0.00164	CcSEcCtD
Tadalafil—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000659	0.00164	CcSEcCtD
Tadalafil—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000657	0.00163	CcSEcCtD
Tadalafil—Infection—Montelukast—chronic obstructive pulmonary disease	0.000657	0.00163	CcSEcCtD
Tadalafil—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000656	0.00163	CcSEcCtD
Tadalafil—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000656	0.00163	CcSEcCtD
Tadalafil—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000654	0.00162	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000651	0.0082	CbGpPWpGaD
Tadalafil—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000651	0.00162	CcSEcCtD
Tadalafil—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000649	0.00161	CcSEcCtD
Tadalafil—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000643	0.0016	CcSEcCtD
Tadalafil—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000638	0.00158	CcSEcCtD
Tadalafil—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000637	0.00802	CbGpPWpGaD
Tadalafil—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000634	0.00157	CcSEcCtD
Tadalafil—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000631	0.00157	CcSEcCtD
Tadalafil—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000631	0.00157	CcSEcCtD
Tadalafil—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000628	0.00156	CcSEcCtD
Tadalafil—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000628	0.00156	CcSEcCtD
Tadalafil—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000626	0.00155	CcSEcCtD
Tadalafil—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000623	0.00155	CcSEcCtD
Tadalafil—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00062	0.00154	CcSEcCtD
Tadalafil—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000617	0.00153	CcSEcCtD
Tadalafil—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000617	0.00153	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000616	0.00153	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000616	0.00153	CcSEcCtD
Tadalafil—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000612	0.0077	CbGpPWpGaD
Tadalafil—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000611	0.00152	CcSEcCtD
Tadalafil—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000611	0.00152	CcSEcCtD
Tadalafil—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000607	0.00151	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000603	0.00759	CbGpPWpGaD
Tadalafil—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000603	0.0015	CcSEcCtD
Tadalafil—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000602	0.0015	CcSEcCtD
Tadalafil—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000602	0.0015	CcSEcCtD
Tadalafil—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000601	0.00149	CcSEcCtD
Tadalafil—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000601	0.00149	CcSEcCtD
Tadalafil—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000599	0.00149	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000596	0.00751	CbGpPWpGaD
Tadalafil—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000596	0.00148	CcSEcCtD
Tadalafil—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000595	0.00148	CcSEcCtD
Tadalafil—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000595	0.00148	CcSEcCtD
Tadalafil—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000594	0.00148	CcSEcCtD
Tadalafil—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000592	0.00147	CcSEcCtD
Tadalafil—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000588	0.00146	CcSEcCtD
Tadalafil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000587	0.00146	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000583	0.00145	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000583	0.00145	CcSEcCtD
Tadalafil—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000583	0.00145	CcSEcCtD
Tadalafil—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000582	0.00145	CcSEcCtD
Tadalafil—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000582	0.00145	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000581	0.00144	CcSEcCtD
Tadalafil—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00058	0.0073	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000578	0.00728	CbGpPWpGaD
Tadalafil—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000578	0.00143	CcSEcCtD
Tadalafil—Pain—Formoterol—chronic obstructive pulmonary disease	0.000578	0.00143	CcSEcCtD
Tadalafil—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000578	0.00143	CcSEcCtD
Tadalafil—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000578	0.00143	CcSEcCtD
Tadalafil—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000577	0.00143	CcSEcCtD
Tadalafil—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000576	0.00143	CcSEcCtD
Tadalafil—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000573	0.00142	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000571	0.00142	CcSEcCtD
Tadalafil—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000571	0.00142	CcSEcCtD
Tadalafil—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000569	0.00141	CcSEcCtD
Tadalafil—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000567	0.00141	CcSEcCtD
Tadalafil—Pain—Montelukast—chronic obstructive pulmonary disease	0.000566	0.00141	CcSEcCtD
Tadalafil—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000566	0.0014	CcSEcCtD
Tadalafil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000564	0.0014	CcSEcCtD
Tadalafil—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000562	0.0014	CcSEcCtD
Tadalafil—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000562	0.00139	CcSEcCtD
Tadalafil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00056	0.00139	CcSEcCtD
Tadalafil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000559	0.00139	CcSEcCtD
Tadalafil—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000558	0.00139	CcSEcCtD
Tadalafil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000556	0.00138	CcSEcCtD
Tadalafil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000554	0.00137	CcSEcCtD
Tadalafil—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000552	0.00137	CcSEcCtD
Tadalafil—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000552	0.00137	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000551	0.00137	CcSEcCtD
Tadalafil—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00055	0.00137	CcSEcCtD
Tadalafil—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000546	0.00135	CcSEcCtD
Tadalafil—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000546	0.00135	CcSEcCtD
Tadalafil—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000541	0.00134	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000538	0.00677	CbGpPWpGaD
Tadalafil—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000537	0.00133	CcSEcCtD
Tadalafil—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000537	0.00133	CcSEcCtD
Tadalafil—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000534	0.00133	CcSEcCtD
Tadalafil—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000534	0.00133	CcSEcCtD
Tadalafil—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000533	0.00671	CbGpPWpGaD
Tadalafil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000532	0.00132	CcSEcCtD
Tadalafil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000528	0.00131	CcSEcCtD
Tadalafil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000527	0.00131	CcSEcCtD
Tadalafil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000527	0.00131	CcSEcCtD
Tadalafil—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000526	0.00131	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000525	0.00661	CbGpPWpGaD
Tadalafil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000524	0.0013	CcSEcCtD
Tadalafil—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000523	0.0013	CcSEcCtD
Tadalafil—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000522	0.0013	CcSEcCtD
Tadalafil—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000522	0.0013	CcSEcCtD
Tadalafil—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000518	0.00129	CcSEcCtD
Tadalafil—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000515	0.00128	CcSEcCtD
Tadalafil—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000512	0.00645	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000508	0.00639	CbGpPWpGaD
Tadalafil—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000507	0.00126	CcSEcCtD
Tadalafil—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000504	0.00125	CcSEcCtD
Tadalafil—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000498	0.00124	CcSEcCtD
Tadalafil—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000498	0.00124	CcSEcCtD
Tadalafil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000497	0.00124	CcSEcCtD
Tadalafil—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000488	0.00121	CcSEcCtD
Tadalafil—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000485	0.0012	CcSEcCtD
Tadalafil—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000485	0.0012	CcSEcCtD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00048	0.00604	CbGpPWpGaD
Tadalafil—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000478	0.00119	CcSEcCtD
Tadalafil—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000478	0.00119	CcSEcCtD
Tadalafil—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000475	0.00118	CcSEcCtD
Tadalafil—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00047	0.00117	CcSEcCtD
Tadalafil—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000468	0.00116	CcSEcCtD
Tadalafil—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000462	0.00115	CcSEcCtD
Tadalafil—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000462	0.00115	CcSEcCtD
Tadalafil—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000458	0.00114	CcSEcCtD
Tadalafil—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000453	0.00112	CcSEcCtD
Tadalafil—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.00112	CcSEcCtD
Tadalafil—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000447	0.00111	CcSEcCtD
Tadalafil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000447	0.00111	CcSEcCtD
Tadalafil—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000438	0.00109	CcSEcCtD
Tadalafil—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000436	0.00108	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000431	0.00543	CbGpPWpGaD
Tadalafil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00043	0.00107	CcSEcCtD
Tadalafil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00043	0.00107	CcSEcCtD
Tadalafil—Rash—Formoterol—chronic obstructive pulmonary disease	0.000426	0.00106	CcSEcCtD
Tadalafil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000426	0.00106	CcSEcCtD
Tadalafil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000426	0.00106	CcSEcCtD
Tadalafil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000426	0.00106	CcSEcCtD
Tadalafil—Headache—Formoterol—chronic obstructive pulmonary disease	0.000423	0.00105	CcSEcCtD
Tadalafil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000423	0.00105	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000423	0.00533	CbGpPWpGaD
Tadalafil—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000423	0.00105	CcSEcCtD
Tadalafil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000422	0.00105	CcSEcCtD
Tadalafil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000421	0.00105	CcSEcCtD
Tadalafil—Rash—Montelukast—chronic obstructive pulmonary disease	0.000417	0.00104	CcSEcCtD
Tadalafil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000417	0.00104	CcSEcCtD
Tadalafil—Headache—Montelukast—chronic obstructive pulmonary disease	0.000415	0.00103	CcSEcCtD
Tadalafil—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000411	0.00102	CcSEcCtD
Tadalafil—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00041	0.00102	CcSEcCtD
Tadalafil—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000409	0.00101	CcSEcCtD
Tadalafil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000406	0.00101	CcSEcCtD
Tadalafil—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000403	0.001	CcSEcCtD
Tadalafil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000402	0.000999	CcSEcCtD
Tadalafil—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000402	0.000999	CcSEcCtD
Tadalafil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000402	0.000998	CcSEcCtD
Tadalafil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000401	0.000997	CcSEcCtD
Tadalafil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000401	0.000997	CcSEcCtD
Tadalafil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.0004	0.000993	CcSEcCtD
Tadalafil—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000394	0.000979	CcSEcCtD
Tadalafil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000393	0.000976	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000389	0.00489	CbGpPWpGaD
Tadalafil—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000388	0.000965	CcSEcCtD
Tadalafil—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000387	0.000961	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000385	0.00484	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000384	0.00484	CbGpPWpGaD
Tadalafil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.000941	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000377	0.00475	CbGpPWpGaD
Tadalafil—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000377	0.000937	CcSEcCtD
Tadalafil—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000377	0.00474	CbGpPWpGaD
Tadalafil—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000376	0.000934	CcSEcCtD
Tadalafil—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000374	0.00093	CcSEcCtD
Tadalafil—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000368	0.000913	CcSEcCtD
Tadalafil—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000366	0.000909	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000363	0.00457	CbGpPWpGaD
Tadalafil—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00036	0.000894	CcSEcCtD
Tadalafil—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000357	0.000887	CcSEcCtD
Tadalafil—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000354	0.000879	CcSEcCtD
Tadalafil—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00035	0.000869	CcSEcCtD
Tadalafil—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000347	0.000863	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000346	0.00436	CbGpPWpGaD
Tadalafil—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00034	0.000843	CcSEcCtD
Tadalafil—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000338	0.00084	CcSEcCtD
Tadalafil—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000331	0.000822	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000329	0.00415	CbGpPWpGaD
Tadalafil—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000329	0.000816	CcSEcCtD
Tadalafil—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000328	0.000814	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000327	0.00412	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000327	0.00411	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000324	0.00408	CbGpPWpGaD
Tadalafil—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000313	0.000777	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000312	0.00393	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000311	0.00392	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00031	0.0039	CbGpPWpGaD
Tadalafil—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000307	0.000763	CcSEcCtD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000305	0.00383	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000301	0.00378	CbGpPWpGaD
Tadalafil—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000298	0.000739	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000294	0.00371	CbGpPWpGaD
Tadalafil—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000293	0.000727	CcSEcCtD
Tadalafil—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000292	0.000726	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000292	0.00367	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000291	0.00367	CbGpPWpGaD
Tadalafil—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000291	0.000722	CcSEcCtD
Tadalafil—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000286	0.000711	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000284	0.00357	CbGpPWpGaD
Tadalafil—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000282	0.000701	CcSEcCtD
Tadalafil—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000281	0.000699	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000279	0.00351	CbGpPWpGaD
Tadalafil—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000277	0.000689	CcSEcCtD
Tadalafil—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000277	0.000689	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000275	0.000684	CcSEcCtD
Tadalafil—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000681	CcSEcCtD
Tadalafil—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000274	0.00345	CbGpPWpGaD
Tadalafil—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00027	0.00067	CcSEcCtD
Tadalafil—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000266	0.00066	CcSEcCtD
Tadalafil—Infection—Prednisone—chronic obstructive pulmonary disease	0.000264	0.000656	CcSEcCtD
Tadalafil—Shock—Prednisone—chronic obstructive pulmonary disease	0.000262	0.00065	CcSEcCtD
Tadalafil—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000261	0.000648	CcSEcCtD
Tadalafil—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000259	0.000645	CcSEcCtD
Tadalafil—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000258	0.000641	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000257	0.00324	CbGpPWpGaD
Tadalafil—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000257	0.000638	CcSEcCtD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000247	0.00311	CbGpPWpGaD
Tadalafil—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000242	0.000602	CcSEcCtD
Tadalafil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000242	0.000601	CcSEcCtD
Tadalafil—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00024	0.000597	CcSEcCtD
Tadalafil—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000239	0.000593	CcSEcCtD
Tadalafil—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000581	CcSEcCtD
Tadalafil—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.000573	CcSEcCtD
Tadalafil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00023	0.000572	CcSEcCtD
Tadalafil—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000569	CcSEcCtD
Tadalafil—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.000569	CcSEcCtD
Tadalafil—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000565	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000227	0.00285	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000225	0.00283	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000221	0.00279	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000218	0.00275	CbGpPWpGaD
Tadalafil—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00054	CcSEcCtD
Tadalafil—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.00054	CcSEcCtD
Tadalafil—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000525	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000211	0.00265	CbGpPWpGaD
Tadalafil—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000522	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000207	0.0026	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000201	0.00253	CbGpPWpGaD
Tadalafil—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000487	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000195	0.00245	CbGpPWpGaD
Tadalafil—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000474	CcSEcCtD
Tadalafil—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000467	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000184	0.00232	CbGpPWpGaD
Tadalafil—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000452	CcSEcCtD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000179	0.00226	CbGpPWpGaD
Tadalafil—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000437	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000175	0.00221	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000174	0.00219	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TP53—chronic obstructive pulmonary disease	0.00017	0.00214	CbGpPWpGaD
Tadalafil—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00042	CcSEcCtD
Tadalafil—Rash—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000416	CcSEcCtD
Tadalafil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000416	CcSEcCtD
Tadalafil—Headache—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000414	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000159	0.002	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000158	0.00199	CbGpPWpGaD
Tadalafil—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000392	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000158	0.00199	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000156	0.00196	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000152	0.00191	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000152	0.00191	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000141	0.00178	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000131	0.00165	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000129	0.00163	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000116	0.00146	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000111	0.0014	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000109	0.00138	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000108	0.00136	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000106	0.00133	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000101	0.00127	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.91e-05	0.00125	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.53e-05	0.0012	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.4e-05	0.00118	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.4e-05	0.00118	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.94e-05	0.00112	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.5e-05	0.00107	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	7.67e-05	0.000965	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.63e-05	0.000961	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.01e-05	0.000882	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.87e-05	0.000865	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.77e-05	0.000726	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.28e-05	0.000665	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.08e-05	0.000639	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.94e-05	0.000622	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.59e-05	0.000578	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.7e-05	0.00034	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.67e-05	0.000336	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.43e-05	0.000306	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.24e-05	0.000282	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.87e-05	0.000235	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.84e-05	0.000232	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.72e-05	0.000216	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.63e-05	0.000205	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.11e-05	0.000139	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.06e-05	0.000133	CbGpPWpGaD
